What is Tango Therapeutics's common stock?

Tango Therapeutics (TNGX) reported common stock of 400M in Q1 2026.

How has Tango Therapeutics's common stock changed year-over-year?

Tango Therapeutics's common stock increased by 100.0% year-over-year, from 200M to 400M.

What is the long-term trend for Tango Therapeutics's common stock?

Over 5 years (2020 to 2025), Tango Therapeutics's common stock has grown at a 449.3% compound annual growth rate (CAGR), from 40K to 200M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Tango Therapeutics TNGX Common Stock

Common Stock at other companies

Bristol-Myers SquibbBMY

$292M0.0%

AmgenAMGN

2.8B0.0%

ExelixisEXEL

400M0.0%

Cogent Biosciences, Inc.COGT

$171K+50.0%

CG OncologyCGON

$9K+12.5%

Lantheus HoldingsLNTH

250M0.0%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's common stock?: Tango Therapeutics (TNGX) reported common stock of 400M in Q1 2026.
How has Tango Therapeutics's common stock changed year-over-year?: Tango Therapeutics's common stock increased by 100.0% year-over-year, from 200M to 400M.
What is the long-term trend for Tango Therapeutics's common stock?: Over 5 years (2020 to 2025), Tango Therapeutics's common stock has grown at a 449.3% compound annual growth rate (CAGR), from 40K to 200M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).